Literature DB >> 7189469

Anti-endotoxin (anti-lipid-A) antibodies.

D Blake, A N Hamlyn, S Proctor, E N Wardle.   

Abstract

Anti-lipid-A, anti-endotoxin, antibodies have been measured by a passive haemolysis test using antigen from an E. coli Re mutant. Titres in the normal population are low but do rise in situations in which there has been gram-negative sepsis. Absence of raised titres in other situations has profound implications.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7189469     DOI： 10.1007/bf01953765

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  8 in total

Review 1.  THE SHWARTZMAN REACTION: PATHOGENETIC MECHANISMS AND CLINICAL MANIFESTATIONS.

Authors:  P F HJORT; S I RAPAPORT
Journal:  Annu Rev Med       Date:  1965       Impact factor: 13.739

2.  Is the pathogenesis of Crohn's disease similar to that juvenile recurrent pyelonephritis? A study of lipid A antibody titers in Crohn's disease, ulcerative colitis and acute enteritis.

Authors:  W Marget; P Schüssler; W Kruis; M Weinzierl; G Rindfleisch
Journal:  Infection       Date:  1976       Impact factor: 3.553

3.  Antibodies against E. coli O-antigens and common enterobacterial antigen in kidney-transplant recipients. Comparison of antibody findings with evidence of urinary tract infection.

Authors:  O F Thomsen; T Hjort
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-12

Review 4.  Fibrin in renal disease: functional considerations.

Authors:  E N Wardle
Journal:  Clin Nephrol       Date:  1974       Impact factor: 0.975

5.  Type-specific and cross-reactive antibodies in gram-negative bacteremia.

Authors:  W R McCabe; B E Kreger; M Johns
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

6.  Antibody response to enterobacterial lipoprotein of patients with varied infections due to Enterobacteriaceae.

Authors:  E K Griffiths; S Yoonessi; E Neter
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

7.  [Occurence, significance and clinical consequences of lipid A antibody titers in patients with urinary tract infection (author's transl)].

Authors:  M Westenfelder; C Galanos; A Withöft; G Lang
Journal:  Infection       Date:  1977       Impact factor: 3.553

8.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes.

Authors:  F Koster; J Levin; L Walker; K S Tung; R H Gilman; M M Rahaman; M A Majid; S Islam; R C Williams
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245
  8 in total
  4 in total

Review 1.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

2.  A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.

Authors:  M Nys; P Damas; F Damas; L Joassin; J Demonty
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Bacteraemic and endotoxic shock.

Authors:  E N Wardle
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

4.  The importance of anti-lipid A (anti-endotoxin): prevention of "shock lung" and acute renal failure.

Authors:  E N Wardle
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.